Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 1/2009

01-01-2009 | For Debate

Preventing hypoglycaemia: what is the appropriate glucose alert value?

Author: P. E. Cryer

Published in: Diabetologia | Issue 1/2009

Login to get access

Excerpt

Everyone is entitled to their own opinion, but not their own facts.
Daniel Patrick Moynihan
…
Literature
1.
Swinnen SGHA, Mullins P, Miller M, Hoekstra JBL, Holleman F (2009) Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia doi:10.​1007/​s00125-008-1147-0
2.
3.
Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in type 2 diabetes. Diabet Med 25:245–254PubMedCrossRef
4.
American Diabetes Association Workgroup on Hypoglycemia (2005) Defining and reporting hypoglycemia in diabetes. Diabetes Care 28:1245–1249CrossRef
5.
The Diabetes Research in Children Network (DirecNet) Study Group (2003) A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther 5:933–941CrossRef
6.
Cryer PE (2001) The prevention and correction of hypoglycemia. In: Jefferson LS, Cherrington AD (eds) Handbook of physiology, Section 7, the endocrine system. Volume II, the endocrine pancreas and regulation of metabolism. Oxford University Press, New York, pp 1057–1092
7.
Schwartz NS, Clutter WE, Shah SD, Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777–781PubMedCrossRef
8.
Mitrakou A, Ryan C, Veneman T et al (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol Endocrinol Metab 260:E67–E74
9.
Fanelli C, Pampanelli S, Epifano L et al (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797–807PubMedCrossRef
10.
Davis SN, Shavers C, Mosqueda-Garcia R, Costa F (1997) Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328–1335PubMedCrossRef
11.
Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV (1988) Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901–907PubMedCrossRef
12.
Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318:1487–1492PubMedCrossRef
13.
Cox DJ, Gonder-Frederick L, Ritterbrand L, Clarke W, Kovatchev BP (2007) Prediction of severe hypoglycemia. Diabetes Care 30:1370–1373PubMedCrossRef
14.
15.
16.
Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J (1992) Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia 35:958–961PubMedCrossRef
17.
Heine RJ (1993) Methods of investigation of insulin-induced hypoglycaemia. In: Frier BM, Fisher BM (eds) Hypoglycaemic in diabetes: clinical and physiological aspects. Arnold, London, pp 165–175
Metadata
Title
Preventing hypoglycaemia: what is the appropriate glucose alert value?
Author
P. E. Cryer
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1205-7

Other articles of this Issue 1/2009

Diabetologia 1/2009 Go to the issue

Article

Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest

Letter

Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity

List of Referees

List of referees

Editorial

Diet, delusion and diabetes

Review

A sub-Saharan African perspective of diabetes

Article

Serum and dietary β-carotene and α-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits